The Pharma Data

NOVEMBER 18, 2020

One serious and 11 other adverse events occurred in the fluvoxamine group, while in the placebo group, there were six serious and 12 other adverse events. More News Resources. Professional. Fluvoxamine Linked to Reduction in Clinical Deterioration in COVID-19. WEDNESDAY, Nov. Lenze, M.D., Lenze, M.D., Abstract/Full Text.

Medicine 52

Medicine Trials Research 52

The Pharma Data

NOVEMBER 16, 2020

16, 2020 — Transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can occur even under supervised quarantine conditions, according to a study published online Nov. 11 in the New England Journal of Medicine. More News Resources. Professional. SARS-CoV-2 Transmitted Despite Quarantine Conditions.

Genome 52

Genome Genomics Medicine Research 52

The Pharma Data

OCTOBER 19, 2020

19, 2020 — A coronavirus strain that has plagued the swine industry in recent years may have the ability to spread to people, researchers say. Swine acute diarrhea syndrome coronavirus (SADS-CoV) has infected swine herds throughout China since its discovery in 2016, according to a new report. MONDAY, Oct. © 2020 HealthDay.

Research 52

Research Scientist 52

pharmaphorum

MAY 21, 2021

Japan has approved two more coronavirus vaccines, while expanding a state of emergency to cover the southern island of Okinawa. This has led to calls for the games to be either cancelled or postponed because of fears it could turn into a “super spreader” event, according to Reuters.

Vaccination 52

Vaccination Vaccine Manufacturing Marketing 52

pharmaphorum

AUGUST 27, 2020

Moderna has said that its coronavirus vaccine stimulated an immune response in older people in phase 1 trials, suggesting that the jab is effective in the age groups most susceptible to COVID-19. There were also no serious adverse events reported. The company’s shares rose about 6% on the news.

Vaccination 110

Vaccination Vaccine Immune Response Antibody 110

Pharma Marketing Network

FEBRUARY 16, 2021

Fast forward to March 2020, you are ready to do the same thing all over again and attend a three-day conference 2,450 miles away from home…until you turn on the news and hear that there’s a global pandemic and lockdown orders have been placed all throughout the U.S. It is important to also discuss what happens when the event is over.

Marketing 52

Marketing Doctors Doctor 52

The Pharma Data

JANUARY 8, 2021

8, 2021 — Progression of mild COVID-19 can be reduced by early administration of high-titer convalescent plasma against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), according to a study published online Jan. 6 in the New England Journal of Medicine. There were no solicited adverse events observed.

Trials 52

Trials Protein Vaccination Vaccine 52

pharmaphorum

JANUARY 11, 2021

Many started the year with big plans, whether for overseas trips, weddings, or industry events, and then the unthinkable happened. While the world first heard of the novel coronavirus in late 2019, it was not until 11 March 2020 that it was declared a global pandemic and it finally sank in just how serious of a threat it was.

Clinical Trials 92

Clinical Trials Clinical Trials Life Science Containment 92

The Pharma Data

DECEMBER 28, 2020

BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus (HPV), and/or to directly inhibit tumours to treat specific types of cancer.

Containment 52

Containment Drug Delivery Compliance Marketing 52

The Pharma Data

OCTOBER 31, 2020

The new guidelines cut down on unnecessary testing while detecting “athletes at increased risk of adverse cardiac events attributable to the virus during their return to sports,” he said in a hospital news release. SOURCE: Massachusetts General Hospital, news release, Oct. 26 in JAMA Cardiology.

Cardiology 52

Cardiology Medicine Development 52

pharmaphorum

APRIL 6, 2021

The roll-out of the third coronavirus shot will come as the UK exits its second lockdown round, and in time to offset an anticipated dip in supply of the Oxford University/AstraZeneca AZD1222 vaccine in the coming weeks. Other countries including Germany and Canada have already banned the use of the AZD1222 in some younger age brackets.

Vaccination 79

Vaccination Vaccine Immune Response Manufacturing 79

The Pharma Data

DECEMBER 14, 2020

14, 2020 (Healthday News) — The first shipments of nearly 3 million doses of the Pfizer coronavirus vaccine were on their way to hospitals in all 50 U.S. coronavirus case count passed 16.3 By Monday, the top five states for coronavirus infections were California with nearly 1.6 MONDAY, Dec. A global scourge.

Vaccination 52

Vaccination Vaccine Nurses Containment 52

The Pharma Data

DECEMBER 23, 2020

The Company advises that it is not making any express or implied claims that Ifenprodil has the ability to eliminate, cure or contain COVID-19 (or the SARS-2 Coronavirus) at this time. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. About NP-120 (Ifenprodil).

Containment 52

Containment Regulation Compliance Development 52

The Pharma Data

JANUARY 18, 2021

Utilizing drug delivery platform technologies, BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus (HPV). Source link.

Containment 40

Containment Regulation Production Drug Delivery 40

The Pharma Data

MARCH 16, 2021

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced that the company will host a virtual investor event to discuss Merck’s broad HIV program and the newly announced collaboration with Gilead Sciences. This news release of Merck & Co., About Merck. Forward-Looking Statement of Merck & Co.,

Development 52

Development Production Containment Research 52

The Pharma Data

DECEMBER 20, 2020

BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus (HPV), and/or to directly inhibit tumours to treat specific types of cancer.

Drug Delivery 52

Drug Delivery Containment Production Development 52

The Pharma Data

JANUARY 12, 2021

12, 2021 (American Heart Association News) — Researchers are soon expected to release initial findings from a national cardiac registry of NCAA athletes who have tested positive for COVID-19 , giving hope to health care professionals trying to better understand the impact of the disease on the heart. TUESDAY, Jan.

Cardiology 52

Cardiology Medicine Doctors Doctor 52

The Pharma Data

JANUARY 11, 2021

News information is not all-inclusive and updates are published once a week on Tuesdays. . . Concern has been building about the new SARS-CoV-2 strain discovered last month in the U.K., Other Industry News. Diagnostics. and on Friday, the U.S. Although the jury is still out, the data is beginning to look promising.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

pharmaphorum

NOVEMBER 9, 2020

The vaccine is based on a strand of messenger RNA – a short segment of genetical material that codes for the “Spike” protein found on the surface of the coronavirus. These cause the body to produce antibodies that neutralise the SARS-CoV-2 virus in the event of an infection.

Vaccination 98

Vaccination Vaccine Clinical Trials Clinical Trials 98

The Pharma Data

MARCH 3, 2021

This news release of Merck & Co., The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. For more information, visit www.merck.com and connect with us on Twitter , Facebook , Instagram , YouTube and LinkedIn.

Production 52

Production Containment Regulation Marketing 52

The Pharma Data

FEBRUARY 25, 2021

This news release of Merck & Co., The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. For more information, visit www.merck.com and connect with us on Twitter , Facebook , Instagram , YouTube and LinkedIn.

Production 52

Production Containment Regulation Manufacturing 52

Pfizer

JANUARY 27, 2023

Nirmatrelvir, which originated in Pfizer laboratories, is designed to block the activity of the M pro , an enzyme that the coronavirus needs to replicate. Serious and unexpected adverse events may occur that have not been previously reported with PAXLOVID use.

Marketing 75

Marketing Production Drugs Licensing 75

The Pharma Data

DECEMBER 14, 2020

BetterLife is refining and developing drug candidates from a broad set of complementary interferon-based technologies which have the potential to engage the immune system to fight virus infections, such as the coronavirus disease (COVID-19) and human papillomavirus (HPV), and/or to directly inhibit tumors to treat specific types of cancer.

Drug Delivery 40

Drug Delivery Containment Manufacturing Drugs 40

Triage Cancer

APRIL 13, 2021

New details about last month’s American Rescue Plan Act continue to emerge, and federal agencies and state officials continue working to address regular business and the pandemic. Triage Cancer remains committed to bringing you the news that might impact the cancer community. . National News. State News. Learn more here.

Nurses 52

Nurses Doctors Doctor Vaccination 52

The Pharma Data

JANUARY 20, 2021

By some estimates, more than half of these patients are rehospitalized within a month of discharge due to a worsening event and approximately one in five die within two years,” said Dr. Paul W. Verquvo met the primary efficacy objective based on a time-to-event analysis (hazard ratio [HR]: 0.90, 95% confidence interval [CI], 0.82-0.98;

FDA Approval 52

FDA Approval Production Trials Clinical Trials 52

The Pharma Data

DECEMBER 14, 2020

Efficacy data were based on an analysis of 36,523 participants in the study who did not have evidence of severe acute respiratory syndrome coronavirus 2 seven days after the second dose; 18,198 received the vaccine and 18,325 received placebo. In an agency news release, FDA Commissioner Stephen M.

Vaccination 52

Vaccination Vaccine Nurses Scientist 52

The Pharma Data

NOVEMBER 8, 2020

The US Food and Drug Administration (FDA) has authorized the restart of AstraZeneca ’s clinical trial for the Oxford coronavirus vaccine AZD1222 in the US, after regulators in the UK, Brazil, South Africa and Japan had already confirmed it was safe to proceed. .

Clinical Trials 40

Clinical Trials Clinical Trials Manufacturing Trials 40

The Pharma Data

JULY 21, 2021

mg, 5 mg, and 10 mg) is indicated for the treatment of symptomatic chronic heart failure in adult patients with reduced ejection fraction who are stabilized after a recent decompensation event requiring intravenous (IV) therapy. Bayer also issued a news release earlier today announcing the EC approval. In the EU, VERQUVO (2.5

Production 52

Production Medicine Containment Development 52

The Pharma Data

NOVEMBER 18, 2020

Joint developers Pfizer and BioNTech released the highly promising efficacy results from their phase 3 trial’s final efficacy analysis, based on 170 confirmed coronavirus cases. The only notable adverse events were fatigue and headache in a small percentage of participants, 3.8 and 2 percent respectively, the companies said.

Vaccination 52

Vaccination Vaccine Immune Response Development 52

The Pharma Data

MAY 4, 2021

There are limited clinical data available for baricitinib use in coronavirus 2019 (COVID-19). Serious and unexpected adverse events may occur that have not been previously reported with bamlanivimab and etesevimab together. Some of these events required hospitalization. See Limitations of Authorized Use.

Antibody 52

Antibody Medicine FDA Approval Licensing 52

The Pharma Data

MAY 4, 2021

INDIANAPOLIS , May 4, 2021 /PRNewswire/ — Eli Lilly and Company (NYSE: LLY) announces new initiatives to help COVID-19 patients in India as part of its commitment to bring the full force of its scientific and medical expertise to attack the coronavirus pandemic around the world.

Licensing 40

Licensing Licensing FDA Approval Development 40

The Pharma Data

FEBRUARY 1, 2021

In clinical trials, the most common adverse events associated with Plegridy were injection site reactions and flu-like symptoms. A list of adverse events can be found in the full Plegridy product labeling for each country where it is approved. MS, the coronavirus and vaccines – updated global advice. 3 Zhao Y, et al.

FDA Approval 40

FDA Approval Bioequivalency Clinical Trials Clinical Trials 40

The Pharma Data

JANUARY 22, 2021

As research developments into RNA vaccines help scientists accelerate drug candidates to arm the immune system against coronavirus, Pharma IQ ’s Keeping tabs on Covid-19 update returns with news from some of the biotechnology innovators leading the fight against the global pandemic. Download this exclusive report here.

Vaccination 52

Vaccination Vaccine Protein Immune Response 52

The Pharma Data

JULY 21, 2021

Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for use in individuals 12 years of age and older. IMPORTANT SAFETY INFORMATION FROM U.S.

Manufacturing 52

Manufacturing Vaccination Vaccine Clinical Trials 52

The Pharma Data

MARCH 2, 2021

This news release of Merck & Co., The company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise. For more information, visit www.merck.com and connect with us on Twitter , Facebook , Instagram , YouTube and LinkedIn.

Vaccination 40

Vaccination Vaccine Manufacturing Medicine 40

The Pharma Data

JANUARY 26, 2021

The Sub-group analysis of the low-risk (low NEWS Score at admission) study cohort (n=181) demonstrated a 3 day earlier discharge in Avigan group compared to placebo group (8 days vs 11 days; p=0.0063) for time to hospital discharge secondary endpoint. The full data analysis on 353 subjects would be available by the end of February 2021.

Life Science 40

Life Science Production Marketing Dermatology 40

The Pharma Data

MAY 7, 2021

Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older. The Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by the U.S. Pfizer Disclosure Notice.

Licensing 52

Licensing Licensing Vaccination Vaccine 52